Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance
Recruiting
Observational Study
Lactose Intolerant
Lactose Malabsorption
Lactose Intolerance
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 385 (estimated)
- Sponsor
- European Institute of Oncology · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Lactose intolerance (LI) is considered the clinical syndrome caused by lactose malabsorption (LM).
It is possible to identify four causes of lactase deficiency defining four different types of LM: primary (genetic), secondary (acquired), congenital (alactasia), and developmental (in premature infants, so reversible).
The aim of this protocol is to investigate through an anonymous online survey t…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Subjects must be adults (≥18 years of age)
* Willingness to complete the online survey
Exclusion Criteria:
* Subjects \<18 years of age
* Subjects not available to answer the online survey
Contacts